Ballentine Partners, LLC Sera Prognostics, Inc. Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q3 2024
A detailed history of Ballentine Partners, LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 49,664 shares of SERA stock, worth $301,957. This represents 0.01% of its overall portfolio holdings.
Number of Shares
49,664
Previous 49,664
-0.0%
Holding current value
$301,957
Previous $294,000
31.63%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding SERA
# of Institutions
64Shares Held
20.3MCall Options Held
120KPut Options Held
0-
Baker Bros. Advisors LP New York, NY5.43MShares$33 Million0.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$18.4 Million0.33% of portfolio
-
Interwest Venture Management CO2.42MShares$14.7 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$10 Million1.88% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$8.57 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $180M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...